Identification of β1,4GalT II as a target gene of p53-mediated HeLa cell apoptosis

Journal of Biochemistry

Volumn 143, Issue 4, 2008, Pages 547-554

  Zhou, Jin ^a   Wei, Yuanyan ^a   Liu, Dan ^a   Ge, Xuqing ^a   Zhou, Fengbiao ^a   Jiang, Xiaojing Yun Jianhai ^a   Gu, Jianxin ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

1,4 galactosyltransferase II; Adriamycin; Apoptosis; p53; Transcription regulation

Indexed keywords

DOXORUBICIN; MESSENGER RNA; PROTEIN P53; BETA1,4 GALACTOSYLTRANSFERASE , HUMAN; BETA1,4-GALACTOSYLTRANSFERASE , HUMAN; COMPLEMENTARY DNA; GALACTOSYLTRANSFERASE; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; BETA1 4 GALACTOSYLTRANSFERASE 2 GENE; CONTROLLED STUDY; DNA DAMAGE; DNA FLANKING REGION; GENE IDENTIFICATION; GENE TARGETING; GENETIC TRANSCRIPTION; HELA CELL; HUMAN; HUMAN CELL; MOLECULAR CLONING; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; REGULATOR GENE; RNA INTERFERENCE; UPREGULATION; FLOW CYTOMETRY; GENETICS; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; WESTERN BLOTTING;

APOPTOSIS; BASE SEQUENCE; BLOTTING, WESTERN; DNA, COMPLEMENTARY; FLOW CYTOMETRY; GALACTOSYLTRANSFERASES; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 41349113352     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvn003     Document Type: Article

References (28)

1. Hannun, Y.A. (1997) Apoptosis and the dilemma of cancer chemotherapy. Blood 89, 1845-1853
2. Sellers, W.R. and Fisher, D.E. (1999) Apoptosis and cancer drug targeting. J. Clin. Invest. 104, 1655-1661
3. Melissa, M., Vanesa, G., Kristine, M.K., and Carol, P. (2007) p53-dependnet p21 mRNA elongation is impaired when DNA replication is stalled. Mol. Cell. Biol. 27, 1309-1320
4. Helton, E.S. and Chen, X. (2007) p53 modulation of the DNA damage response. J. Cell. Biochem. 100, 883-896
5. Fulop, N., Marchase, R.B., and Chatham, J.C. (2007) Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system. Cardiovasc. Res. 73, 288-297
6. Gu, J. and Taniguchi, N. (2004) Regulation of integrin functions by N-glycans. Glycoconjug. J. 21, 9-15
7. Naor, D., Sionov, R.V., and Ish-Shalom, D. (1997) CD44: structure, function, and association with the malignant process. Adv. Cancer Res. 71, 241-319
8. Guo, S., Sato, T., Shirane, K., and Furukawa, K. (2001) Galactosylation of N-linked oligosaccharides by human beta-1,4-galactosyltransferases I, II, III, IV, V, and VI expressed in Sf-9 cells. Glycobiology 11, 813-820
9. Lo, N.W., Shaper, J.H., Pevsner, J., and Shaper, N.L. (1998) The expanding beta 4-galactosyltransferase gene family: messages from the databanks. Glycobiology 8, 517-526
10. Sasaki, N., Manya, H., Okubo, R., Kobayashi, K., Ishida, H., Toda, T., Endo, T., and Nishihara, S. (2005) beta4GalT-II is a key regulator of glycosylation of the proteins involved in neuronal development. Biochem. Biophys. Res. Commun. 333, 131-137
11. Jiang, J., Zhou, J., Wei, Y., Shen, J., Liu, D., Chen, X., Zhang, S., Kong, X., Yun, X., and Gu, J. (2007) beta4GalT-II increases cisplatin-induced apoptosis in HeLa cells depending on its Golgi localization. Biochem. Biophys. Res. Commun. 358, 41-46
12. Jiang, J., Shen, J., Wu, T., Wei, Y., Chen, X., Zong, H., Zhang, S., Sun, M., Xie, J., Kong, X., Yang, Y., Shen, A., Wang, H., and Gu, J. (2006) Down-regulation of beta1,4-galactosyltransferase V is a critical part of etoposide-induced apoptotic process and could be mediated by decreasing Sp1 levels in human glioma cells. Glycobiology 16, 1045-1051
13. Li, Z., Wang, H., Zong, H., Sun, Q., Kong, X., Jiang, J., and Gu, J. (2005) Downregulation of beta1,4-galactosyltransferase 1 inhibits CDK11(p58)-mediated apoptosis induced by cycloheximide. Biochem. Biophys. Res. Commun. 327, 628-636
14. Zhu, X., Jiang, J., Shen, H., Wang, H., Zong, H., Li, Z., Yang, Y., Niu, Z., Liu, W., Chen, X., Hu, Y., and Gu, J. (2005) Elevated beta1,4- galactosyltransferase I in highly metastatic human lung cancer cells. Identification of E1AF as important transcription activator. J. Biol. Chem. 280, 12503-12516
15. Jiang, J., Chen, X., Shen, J., Wei, Y., Wu, T., Yang, Y., Wang, H., Zong, H., Yang, J., Zhang, S., Xie, J., Kong, X., Liu, W., and Gu, J. (2006) Beta1,4-galactosyltransferase V functions as a positive growth regulator in glioma. J. Biol. Chem. 281, 9482-9489
16. Jiang, J., Wei, Y., Liu, D., Zhou, J., Shen, J., Chen, X., Zhang, S., Kong, X., and Gu, J. (2007) E1AF promotes breast cancer cell cycle progression via upregulation of Cyclin D3 transcription. Biochem. Biophys. Res. Commun. 358, 53-58
17. Shirane, K., Sato, T., Segawa, K., and Furukawa, K. (1999) Involvement of beta-1,4-galactosyltransferase V in malignant transformation-associated changes in glycosylation. Biochem. Biophys. Res. Commun. 265, 434-438
18. Rieger, K.E. and Chu, G. (2004) Portrait of transcriptional responses to ultraviolet and ionizing radiation in human cells. Nucleic Acids Res. 32, 4786-4803
19. Sato, T. and Furukawa, K. (2004) Transcriptional regulation of the human beta-1,4-galactosyltransferase V gene in cancer cells: essential role of transcription factor Sp1. J. Biol. Chem. 279, 39574-39583
20. Rajput, B., Shaper, N.L., and Shaper, J.H. (1996) Transcriptional regulation of murine beta1,4-galactosyltransferase in somatic cells. Analysis of a gene that serves both a housekeeping and a mammary gland-specific function. J. Biol. Chem. 271, 5131-5142
21. Kaczynski, J., Cook, T., and Urrutia, R. (2003) Sp1- and Kruppel-like transcription factors. Genome Biol. 4, 206
22. Leri, A., Claudio, P.P., Li, Q., Wang, X., Reiss, K., Wang, S., Malhotra, A., Kajstura, J., and Anversa, P. (1998) Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J. Clin. Invest. 101, 1326-1342
23. Halazonetis, T.D. and Bartek, J. (2006) DNA damage signaling recruits the RNA polymerase II binding protein Che-1 to the p53 promoter. Mol. Cell 24, 809-810
24. Jiang, M.C., Luo, S.F., Li, L.T., Lin, C.C., Du, S.Y., Lin, C.Y., Hsu, Y.W., and Liao, C.F. (2007) Synergic CSE1L/CAS, TNFR-1, and p53 apoptotic pathways in combined interferon-gamma/adriamycin-induced apoptosis of Hep G2 hepatoma cells. J. Exp. Clin. Cancer Res. 26, 91-99
25. Yonesaka, K., Tamura, K., Kurata, T., Satoh, T., Ikeda, M., Fukuoka, M., and Nakagawa, K. (2006) Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin. Int. J. Cancer 118, 812-820
26. Vayssade, M., Haddada, H., Faridoni-Laurens, L., Tourpin, S., Valent, A., Benard, J., and Ahomadegbe, J.C. (2005) P73 functionally replaces p53 in Adriamycin-treated, p53-deficient breast cancer cells. Int. J. Cancer 116, 860-869
27. Wallace, K.B. (2007) Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis. Cardiovasc. Toxicol. 7, 101-107
28. Singal, P.K., Iliskovic, N., Li, T., and Kumar, D. (1997) Adriamycin cardiomyopathy: pathophysiology and prevention. FASEB J. 11, 931-936